Document Detail

Surfactant and the neonatal lung.
MedLine Citation:
PMID:  9509038     Owner:  NLM     Status:  MEDLINE    
Deficiency of pulmonary surfactant is responsible for a substantial proportion of the mortality and morbidity in infants born prematurely. Surfactant replacement therapy has been extensively investigated and has become a central part of neonatal intensive care in the UK over the last 3 years. Evidence for the efficacy of this treatment is provided as is a discussion of the different surfactant preparations available and different protocols for administration.
A T Gibson
Related Documents :
686068 - Modification of ovine fetal respiratory-like activity by chronic diazepam administration.
9200358 - A multicenter randomized masked comparison trial of synthetic surfactant versus calf lu...
19057608 - Developing a systems approach to prevent meconium aspiration syndrome: lessons learned ...
24751628 - The developing intestinal microbiome: probiotics and prebiotics.
21948638 - Feeding issues and interventions in infants and children with clefts and craniofacial s...
18771508 - Maternal brain response to own baby-cry is affected by cesarean section delivery.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  British journal of hospital medicine     Volume:  58     ISSN:  0007-1064     ISO Abbreviation:  Br J Hosp Med     Publication Date:    1997 Oct 15-Nov 4
Date Detail:
Created Date:  1998-04-03     Completed Date:  1998-04-03     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0171545     Medline TA:  Br J Hosp Med     Country:  ENGLAND    
Other Details:
Languages:  eng     Pagination:  381-4, 397     Citation Subset:  IM    
Jessop Hospital for Women, Sheffield.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Clinical Protocols
Cost-Benefit Analysis
Infant, Newborn
Pulmonary Surfactants* / deficiency,  metabolism,  therapeutic use
Randomized Controlled Trials as Topic
Respiratory Distress Syndrome, Newborn / drug therapy*,  mortality
Surface-Active Agents / administration & dosage,  economics,  therapeutic use*
Reg. No./Substance:
0/Pulmonary Surfactants; 0/Surface-Active Agents

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Provision of paediatric intensive care services.
Next Document:  Economics of vascular surgery.